Getting Mounjaro from a doctor: what the evidence and regulations actually say

Why NICE and the MHRA both insist on a prescriber, not just a purchase

The requirement for a prescription isn't bureaucracy for its own sake. When the MHRA licensed Mounjaro for weight management, it did so on the basis of a tightly controlled trial programme. NICE's appraisal of tirzepatide, TA1026 published in December 2024, recommended the medicine for NHS use within specific criteria precisely because its benefit-to-risk balance depends on who is using it and how they are monitored. Tirzepatide slows gastric emptying and works across two gut-hormone receptors, GIP and GLP-1, in ways that affect blood sugar, appetite and, in people with certain conditions, how other medicines are absorbed. Oral contraceptives are one example: absorption can be reduced during the first four weeks of treatment and after each dose increase, so women on the pill are advised to add a barrier method during those windows. None of this complexity is flagged by a checkout page. A prescriber surfaces it. There is also the question of counterfeit supply. The MHRA has seized roughly 20 million doses of illegally traded weight-loss medicines (street value around £45 million), including fake tirzepatide pens. The safe route is a pharmacy you can verify on the GPhC register, dispensing against a real prescription.

GP versus online prescriber: the clinical difference is smaller than people assume

A common misconception is that an online consultation is somehow less rigorous than a face-to-face GP appointment. It is worth letting that go. The legal standard for prescribing is the same regardless of the channel: the prescriber must assess you, satisfy themselves that the medicine is appropriate and safe for you specifically, and take clinical responsibility for the decision. At a regulated online pharmacy, that assessment includes identity verification with photo ID, live weight verification by video, a review of your health history and current medicines, and (for repeat orders) a clinical re-review before each new supply. The prescriber is a named, GPhC-registered professional. You can read about our clinical team and the oversight model before you start. What the online route does differently from a GP surgery is remove the wait. Many people find their GP either won't prescribe Mounjaro privately or has a long queue for the discussion. A registered online prescriber for Mounjaro can review your consultation and, if the medicine is clinically suitable, issue a prescription the same day. The clinical bar is not lower. The waiting time is.

What happens when a prescriber reviews your Mounjaro consultation

The practical steps matter, so here they are plainly. You complete a structured health questionnaire covering your BMI, medical history, current medications and relevant conditions. A GPhC-registered Independent Prescriber reads it the same day, a real clinician, not a queuing algorithm. They check whether you meet the licensed criteria for tirzepatide, whether any of your other medicines or health conditions affect suitability, and whether there are any contraindications. Mounjaro is not recommended during pregnancy, breastfeeding or if you are trying to conceive; it is not licensed for under-18s, and eligibility criteria around age are assessed as part of every consultation; people with a history of medullary thyroid carcinoma or MEN2 syndrome need prescriber discussion before use. The NHS patient-level guidance on tirzepatide gives a clear overview of who should avoid it. If the prescriber approves the prescription, treatment is dispatched from our GPhC-registered pharmacy the same working day for orders placed before noon, arriving by DPD the next working day in plain, unbranded packaging. For dose increases, evidence of your current treatment and progress is reviewed each time. There is no auto-renewal; every supply is a fresh clinical decision. If you are wondering whether your GP can refer you or simply write the prescription themselves, the page on asking your GP about Mounjaro covers that territory in more detail.

Cost context and what the prescription includes

Mounjaro's list price in the UK rose significantly from September 2025, the highest-dose pen's list price moved from around £122 to roughly £330 for a four-week supply, according to widely reported Eli Lilly UK announcements. Private market prices since then have ranged from approximately £149 to £375 per month depending on dose and provider. That context sits on our breakdown of the Lilly price increase if you want the detail. If you are also weighing up which injectable to use, our page comparing Rybelsus and Mounjaro sets out the clinical differences to help inform that conversation with your prescriber. At nume, one price covers the clinical consultation, the prescription, the medicine, free next-working-day tracked delivery and priority aftercare seven days a week. We are not the cheapest option available, that is a deliberate choice, not an oversight. For a prescription medicine, the question isn't which listing is lowest; it's whether the clinical review, the supply chain and the ongoing support are real. On our treatment page you'll find current pricing and can start a free consultation. The prescriber decides; the price follows from what they approve.